BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 19 filers reported holding BIOPHARMX CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,000 | +200.0% | 38,029 | +815.3% | 0.00% | – |
| Q3 2018 | $1,000 | -50.0% | 4,155 | -62.4% | 0.00% | – |
| Q2 2018 | $2,000 | -87.5% | 11,051 | -84.3% | 0.00% | – |
| Q1 2018 | $16,000 | +300.0% | 70,367 | +108.5% | 0.00% | – |
| Q4 2017 | $4,000 | +33.3% | 33,753 | +207.9% | 0.00% | – |
| Q3 2017 | $3,000 | +50.0% | 10,961 | +116.4% | 0.00% | – |
| Q2 2017 | $2,000 | -33.3% | 5,064 | -29.1% | 0.00% | – |
| Q4 2016 | $3,000 | -25.0% | 7,147 | -8.8% | 0.00% | – |
| Q3 2016 | $4,000 | -42.9% | 7,839 | -25.2% | 0.00% | – |
| Q2 2016 | $7,000 | +250.0% | 10,484 | +753.7% | 0.00% | – |
| Q4 2015 | $2,000 | -90.0% | 1,228 | -93.6% | 0.00% | – |
| Q3 2015 | $20,000 | +566.7% | 19,264 | +1826.4% | 0.00% | – |
| Q2 2015 | $3,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 12,814,286 | $6,471,000 | 1.90% |
| RTW INVESTMENTS, LP | 1,283,951 | $648,000 | 0.17% |
| Sio Capital Management, LLC | 313,717 | $158,000 | 0.09% |
| DAFNA Capital Management LLC | 115,000 | $58,000 | 0.05% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 28,027 | $14,000 | 0.00% |
| Baker Brothers Advisors | 377,295 | $191,000 | 0.00% |
| Virtu KCG Holdings LLC | 107,994 | $55,000 | 0.00% |
| FRANKLIN RESOURCES INC | 9,499,615 | $4,797,000 | 0.00% |
| Moors & Cabot, Inc. | 13,000 | $7,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 17,274 | $8,000 | 0.00% |